Influenza Diagnostics Market, By Test Type (Rapid Influenza Diagnostic Tests, Reverse Transcription Polymerase Chain Reaction, and Cell Culture), by End Use (Point of Care Testing, Clinical Laboratories, and Hospitals), and By Geography (NA, EU, APAC, LATAM and MEA) Analysis, Share, Trends, Size, & Forecast From 2020 2026
- Published Date: 2020-10-13
- Report ID: 1797
- Pages: 169
-
Format:
REPORT HIGHLIGHT
Influenza diagnostics market was valued at USD 2.83 billion by 2019, growing with 6.1% CAGR during the forecast period, 2020-2026
Market Dynamics
The growing prevalence of chronic diseases such as blood disorder, heart disorders, and diabetes and the increasing geriatric population all across the globe are the major factors boosting the growth of the global influenza diagnostics market. In addition, the emergence of advancements in technology for diagnostic tests and increasing government initiatives for countering influenza are other factors impelling market growth.
The immunosuppresses individuals, especially those suffering from chronic diseases, are more susceptible to influenza and thus, the demand for influenza diagnostic products is been increasing. The data presented by Centers for Disease Control and Prevention (CDC), approximately 85 laboratory-confirmed paediatric deaths were witnessed in Puerto Rico, District of Columbia, and 33 other states. In 2016, the mortality due to influenza in the U.S. was 4,605, which indicated 1.4 deaths per 100,000 individuals. However, the mutation of the virus serotype is predicted to hinder the market growth during the forecast period.
Test Type Takeaway
The rapid influenza diagnostic tests (RIDT) segment accounted for the largest market share in 2019 and is expected to grow at a healthy growth rate during the forecast period. This is mainly because these test types are frequently used for the diagnosis of influenza. Moreover, RIDT is considered as the gold standard test working for the diagnosis of influenza and delivers quick results, which is further estimated to dominate the global market by 2030. On the other hand, the cell culture test type is commonly considered as a reference method and is extensively used when the incidence rate of the disease is being tested. This test type provides accurate statistics along with an ability to precisely distinguish between the several types of influenza viruses. Thus, the cell culture segment is estimated to grow at an impressive growth rate during the period of forecast.
End Use Takeaway
The hospitals end-use segment for overall influenza diagnostics registered for the majority of market share in 2019 and is projected to steadily slow down owing to the advent of POCT laboratories as these laboratories deliver accurate results. Thus, the POCT end use segment is anticipated to grow at the fastest growth rate by 2030 owing to its ease of use and advantage that it can be used by anyone without any requirement for expertise. In addition, with the advent POCT of advanced technology, the reliance of the physicians and the public on these tests has increased significantly.
Regional Takeaway
Presently, the North America region is leading the overall influenza diagnostics market attributing to a strong focus of the CDC on regulating the disease rates. Additionally, the high technological advancements in this region coupled with the rising healthcare spending are projected to propel the regional market growth by 2030. On the other hand, the Asia Pacific market for influenza diagnostics is projected to witness the fastest growth owing to factors such as significant disease burden and high population density in the region.
Key players of the market include:
Quidel Corporation
Alere, Inc.
Roche Diagnostics
Siemens Healthineers
Abbott Laboratories
Dickinson and Company
Becton
Thermo Fisher Scientific
Bio-Rad Laboratories, Inc.
The market size and forecast for each segment and sub-segments has been considered as below:
Historical Year 2015 to 2018
Base Year 2019
Estimated Year 2020
Projected Year 2026
TARGET AUDIENCE
Traders, Distributors, and Suppliers
Manufacturers
Government and Regional Agencies
Research Organizations
Consultants
Distributors
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL INFLUENZA DIAGNOSTICS MARKET, BY TEST TYPE
Rapid Influenza Diagnostic Tests (RIDT)
Reverse Transcription Polymerase Chain Reaction (RT-PCR)
Cell Culture
Others
GLOBAL INFLUENZA DIAGNOSTICS MARKET, BY END USE
Hospitals
Point of Care Testing (POCT)
Clinical Laboratories
Others
GLOBAL INFLUENZA DIAGNOSTICS MARKET, BY REGION
North America
o The U.S.
o Canada
Europe
o Germany
o France
o Italy
o Spain
o United Kingdom
o Rest of Europe
Asia Pacific
o India
o China
o South Korea
o Japan
o Singapore
o Rest of APAC
Latin America
o Brazil
o Mexico
o Argentina
o Rest of LATAM
Middle East and Africa
o Saudi Arabia
o United Arab Emirates
o Rest of MEA
TABLE OF CONTENT
1. INFLUENZA DIAGNOSTICS MARKET OVERVIEW
1.1. Study Scope
1.2. Assumption and Methodology
2. EXECUTIVE SUMMARY
2.1. Market Snippet
2.1.1. Market Snippet by Test Type
2.1.2. Market Snippet by End Use
2.1.3. Market Snippet by Region
2.2. Competitive Insights
3. INFLUENZA DIAGNOSTICS KEY MARKET TRENDS
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. INFLUENZA DIAGNOSTICS INDUSTRY STUDY
4.1. Porters Five Forces Analysis
4.2. Marketing Strategy Analysis
4.3. Pipeline Analysis (Potential Phase III Candidates)
4.4. Growth Prospect Mapping
4.5. Regulatory Framework Analysis
4.6. COVID-19 Impact Analysis
4.6.1. Pre-COVID-19 Impact Analysis
4.6.2. Post-COVID-19 Impact Analysis
5. INFLUENZA DIAGNOSTICS MARKET LANDSCAPE
5.1. Market Share Analysis
5.2. Key Innovators
5.3. Breakdown Data, by Key manufacturer
5.3.1. Established Player Analysis
5.3.2. Emerging Player Analysis
6. INFLUENZA DIAGNOSTICS MARKET BY TEST TYPE
6.1. Overview
6.1.1. Segment Share Analysis, By Test Type, 2019 & 2026 (%)
6.2. Rapid Influenza Diagnostic Tests (RIDT)
6.2.1. Overview
6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
6.3. Reverse Transcription Polymerase Chain Reaction (RT-PCR)
6.3.1. Overview
6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
6.4. Cell Culture
6.4.1. Overview
6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
6.5. Others
6.5.1. Overview
6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
7. INFLUENZA DIAGNOSTICS MARKET BY END USE
7.1. Overview
7.1.1. Segment Share Analysis, By End Use, 2019 & 2026 (%)
7.2. Hospitals
7.2.1. Overview
7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
7.3. Point of Care Testing (POCT)
7.3.1. Overview
7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
7.4. Clinical Laboratories
7.4.1. Overview
7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
7.5. Others
7.5.1. Overview
7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8. INFLUENZA DIAGNOSTICS MARKET BY GEOGRAPHY
8.1. Introduction
8.1.1. Segment Share Analysis, By Region, 2019 & 2026 (%)
8.2. North America
8.2.1. Overview
8.2.2. Key Manufacturers in North America
8.2.3. North America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
8.2.4. North America Market Size and Forecast, By Test Type, 2015 - 2026 (US$ Million)
8.2.5. North America Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)
8.2.6. U.S.
8.2.6.1. Overview
8.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8.2.7. Canada
8.2.7.1. Overview
8.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8.3. Europe
8.3.1. Overview
8.3.2. Key Manufacturers in Europe
8.3.3. Europe Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
8.3.4. Europe Market Size and Forecast, By Test Type, 2015 - 2026 (US$ Million)
8.3.5. Europe Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)
8.3.6. Germany
8.3.6.1. Overview
8.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8.3.7. Italy
8.3.7.1. Overview
8.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8.3.8. United Kingdom
8.3.8.1. Overview
8.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8.3.9. France
8.3.9.1. Overview
8.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8.3.10. Rest of Europe
8.3.10.1. Overview
8.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8.4. Asia Pacific (APAC)
8.4.1. Overview
8.4.2. Key Manufacturers in Asia Pacific
8.4.3. Asia Pacific Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
8.4.4. Asia Pacific Market Size and Forecast, By Test Type, 2015 - 2026 (US$ Million)
8.4.5. Asia Pacific Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)
8.4.6. India
8.4.6.1. Overview
8.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8.4.7. China
8.4.7.1. Overview
8.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8.4.8. Japan
8.4.8.1. Overview
8.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8.4.9. South Korea
8.4.9.1. Overview
8.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8.4.10. Rest of APAC
8.4.10.1. Overview
8.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8.5. Latin America
8.5.1. Overview
8.5.2. Key Manufacturers in Latin America
8.5.3. Latin America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
8.5.4. Latin America Market Size and Forecast, By Test Type, 2015 - 2026 (US$ Million)
8.5.5. Latin America Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)
8.5.6. Brazil
8.5.6.1. Overview
8.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8.5.7. Mexico
8.5.7.1. Overview
8.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8.5.8. Argentina
8.5.8.1. Overview
8.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8.5.9. Rest of LATAM
8.5.9.1. Overview
8.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8.6. Middle East and Africa
8.6.1. Overview
8.6.2. Key Manufacturers in Middle East and Africa
8.6.3. Middle East and Africa Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
8.6.4. Middle East and Africa Market Size and Forecast, By Test Type, 2015 - 2026 (US$ Million)
8.6.5. Middle East and Africa Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)
8.6.6. Saudi Arabia
8.6.6.1. Overview
8.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8.6.7. United Arab Emirates
8.6.7.1. Overview
8.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
9. KEY VENDOR ANALYSIS
9.1. Quidel Corporation
9.1.1. Company Snapshot
9.1.2. Financial Performance
9.1.3. Product Benchmarking
9.1.4. Strategic Initiatives
9.2. Alere, Inc.
9.3. Roche Diagnostics
9.4. Siemens Healthineers
9.5. Abbott Laboratories
9.6. Dickinson and Company
9.7. Becton
9.8. Thermo Fisher Scientific
9.9. Bio-Rad Laboratories, Inc.
10. 360 DEGREE ANALYSTVIEW
11. APPENDIX
11.1. Research Methodology
11.2. References
11.3. Abbreviations
11.4. Disclaimer
11.5. Contact Us
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
